Summary
- Current Price
- As of today, GLMD price is $0.54, up +1.89% on
- Current Price All-Time High
- GLMD price is currently -99.83% below its historical high of $324.72 set on
- Market Cap
- GLMD current market cap is $3M, down -12.64% year-over-year
- PE Ratio
- GLMD PE ratio is unknown
- Revenue
- GLMD current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for GLMD has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Galmed Pharmaceuticals Ltd. |
| Ticker | NASDAQ: GLMD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | galmedpharma.com |
| Employees | 3 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.54 | ||
| Price, 1D Change | +1.89% | |
| $3M | ||
| - | ||
| - | ||
| 1.31 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.39 | ||
| EPS, 1Y Change | +70.39% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.39 | ||
| EPS Estimate | N/A | -$0.85 |
| EPS Est. Change | N/A | +64.45% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.54 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.29 | -$8.08 | -526.02% | |
| -$2.31 | -$2.39 | -3.52% | |
| -$0.85 | N/A | +64.45% | |
| -$0.55 | N/A | +77.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -64.00% | ||
| -89.46% | ||
| -12.64% | ||
| +312.45% | ||
| 0.00% | ||
| 0.00% | ||
| +70.39% | ||
| +98.13% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.54 | ||
| $1.18 | ||
| SMA 200 vs Price | +118.41% | |
| $0.63 | ||
| SMA 50 vs Price | +16.81% | |
| 1.31 | ||
| $0.05 | ||
| 42.50 | ||
| 97.33% | ||
| 85.09% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.39 | ||
| $0.00 | ||
| - | ||
| -$8.51M | ||
| - | ||
| -$10.31M | ||
| - | ||
| -$8.51M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 6.55 | ||
| 6.55 | ||
| - | ||
| - | ||
| -15.71 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.19 | ||
| 1.80 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $15.78M | ||
| $18.28M | ||
| $18.63M | ||
| $18.63M | ||
| $2.85M | ||
| $2.85M | ||
| $0.00 | ||
| $0.00 | ||
| $2.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $10.31M | ||
| $8.51M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$6.32M | ||
| -$3.38M | ||
| $9.03M | ||
| $0.00 | ||
| -$6.32M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | → | |
| Maxim Group | → | |
| Maxim Group | → | |
| Canaccord Genuity | → | |
| Raymond James | → | |
| Raymond James | ||
| HC Wainwright & Co. | → | |
| Canaccord Genuity | ||
| HC Wainwright & Co. | ||
| Raymond James |
Analyst sentiment
Institutional ownership
Screeners with GLMD
FAQ
What is the ticker symbol for Galmed Pharmaceuticals Ltd.?
The ticker symbol for Galmed Pharmaceuticals Ltd. is NASDAQ:GLMD
Does Galmed Pharmaceuticals Ltd. pay dividends?
No, Galmed Pharmaceuticals Ltd. does not pay dividends
What sector is Galmed Pharmaceuticals Ltd. in?
Galmed Pharmaceuticals Ltd. is in the Healthcare sector
What industry is Galmed Pharmaceuticals Ltd. in?
Galmed Pharmaceuticals Ltd. is in the Biotechnology industry
What country is Galmed Pharmaceuticals Ltd. based in?
Galmed Pharmaceuticals Ltd. is headquartered in Israel
When did Galmed Pharmaceuticals Ltd. go public?
Galmed Pharmaceuticals Ltd. initial public offering (IPO) was on March 13, 2014
Is Galmed Pharmaceuticals Ltd. in the S&P 500?
No, Galmed Pharmaceuticals Ltd. is not included in the S&P 500 index
Is Galmed Pharmaceuticals Ltd. in the NASDAQ 100?
No, Galmed Pharmaceuticals Ltd. is not included in the NASDAQ 100 index
Is Galmed Pharmaceuticals Ltd. in the Dow Jones?
No, Galmed Pharmaceuticals Ltd. is not included in the Dow Jones index
When was Galmed Pharmaceuticals Ltd. last earnings report?
Galmed Pharmaceuticals Ltd.'s most recent earnings report was on November 7, 2022
When does Galmed Pharmaceuticals Ltd. report earnings?
The date for Galmed Pharmaceuticals Ltd.'s next earnings report has not been announced yet
Data Sources & References
- GLMD Official Website galmedpharma.com
- GLMD Profile on Yahoo Finance finance.yahoo.com/quote/GLMD
- GLMD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/glmd